Header cover image

Indian Pharmaceuticals & Biotech Buy the Dip

UPDATED Aug 16, 2022

Companies which may present a buying opportunity after a dip in share price.

12 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
STARStrides Pharma Science₹356.403.1%-43.6%₹32.0b₹449.00PB1.4xE128.4%0%
532482Granules India₹326.958.4%-5.0%₹81.2b₹343.13PE19.3xE18.0%0.5%
500259Lyka Labs₹117.45-1.0%55.3%₹3.4bn/aPE16.9xn/an/a
539997Kwality Pharmaceuticals₹299.05-0.3%-31.4%₹3.1bn/aPE2.6xn/a0%
524652Ind-Swift₹9.98-1.0%9.3%₹540.6mn/aPE-1.7xn/a0%
542678Cian Healthcare₹13.00-14.4%-15.9%₹324.9mn/aPB0.6xn/an/a
526953Venus Remedies₹215.554.5%-57.5%₹2.9bn/aPE8xn/a0%
542724Earum Pharmaceuticals₹2.58-9.8%-87.3%₹159.1mn/aPE2.5xn/an/a
538837Jeevan Scientific Technology₹62.55-10.9%-32.9%₹957.1mn/aPE6.3xn/a0.8%
524768Emmessar Biotech & Nutrition₹24.10-10.1%-30.2%₹120.4mn/aPE12.6xn/an/a
524400Ishita Drugs and Industries₹46.001.1%22.7%₹137.6mn/aPE17.1xn/an/a
537253Sunil Healthcare₹110.058.9%233.5%₹1.1bn/aPE10.9xn/an/a
Page 1 of 1